Norbrook's new CEO says Newry firm has undergone "significant transformation" after profits squeezed from India and China – The Irish News
The Newry veterinary pharmaceuticals group Norbrook saw it profits squeezed to the lowest level in more than a decade during 2023, as the company faced increased competition from India and China.